A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Medicines pricing and reimbursement: innovation, competitiveness, and access
2022
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Access to medicines is a key component for ensuring the universal right to health and for "Promoting health throughout the life cycle and universal health coverage (UHC)", one of the Sustainable Development Goals (SDG). It accounts for one of the main health expenditures. Most new medicines, which are increasingly expensive, do not always offer added therapeutic benefits in relation to existing options, nor are the benefits proportional to their high prices. 1 At the same time, incentives to
doi:10.30968/rbfhss.2022.131.0679
doaj:87ce02a5097a460aa77b838b0b1c99f6
fatcat:ts2rgeogzfc75e3yc23luwptuq